Riskpilot← Back to searchSign inGet full accessStockholmsguldsmed AB
ABBankruptOrg 5569682973Manufacture of jewellery and related articles · NACE 3212Est. 20140 employees
Revenue 2021
SEK 881K
-56% vs 2020
EBITDA margin
-136.2%
-11% vs 2020
Equity ratio
-87.2%
Financial strength
Net profit 2021
SEK -1,3M
-17% vs 2020
| Revenue | SEK 881K | -56% |
| EBITDA | SEK -1,2M | -11% |
| Net profit | SEK -1,3M | -17% |
| Total assets | SEK 2,5M | -5% |
| Equity | SEK -2,1M | -154% |
| Employees | 0 | — |
Legal name
Stockholmsguldsmed AB
Org number
5569682973
Legal form
Aktiebolag
NACE code
3212 · Manufacture of jewellery and related articles
Founded
10 april 2014
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva import och export av guld, diamanter, ädelstenar, äga och förvalta fastigheter, bedriva handel med värdepapper samt annan därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 130 | 25 | 1 103 | 2 016 | 881 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −56 | −50 | 431 | −1 080 | −1 200 |
| Depreciation & amort. | −0 | −0 | −70 | −91 | −91 |
| EBIT | −56 | −50 | 361 | −1 171 | −1 291 |
| Net financials | −1 | −1 | — | −2 | −4 |
| Profit before tax | −57 | −50 | 296 | −1 108 | −1 295 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −57 | −50 | 296 | −1 108 | −1 295 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 245 | 189 | 2 014 | 2 570 | 2 451 |
| Equity | 140 | 89 | 265 | −843 | −2 138 |
| Long-term debt | 5 | 61 | 1 397 | 2 091 | 2 135 |
| Short-term debt | 100 | 39 | 287 | 1 323 | 2 455 |
| Total debt | 105 | 100 | 1 684 | 3 414 | 4 590 |
EBITDA margin
-136.2%
This company
15.8%
Market median
-962% vs market
20172021
Equity ratio
-87.2%
This company
38.2%
Market median
-328% vs market
20172021
Return on equity
-129500000.0%
This company
18.4%
Market median
-703804448% vs market
20172021
Net profit margin
-147.0%
This company
8.1%
Market median
-1915% vs market
20172021
Asset turnover
0.36×
This company
1.12×
Market median
-68% vs market
20172021
Debt / equity
2.15×
This company
0.62×
Market median
-247% vs market
20172021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2022 | |
| Former (2) | ||
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2020 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Stockholmsguldsmed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Charbel Salame | Board of Directors | 0 companies |
| Elias Antoine Kreidy | Deputy Board Member | 0 companies |
| Yacoub Barsoum | Deputy Board Member | 0 companies |
| Michelin Diana Salame | Deputy Board Member | 0 companies |